台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    97.3
  • 漲跌
    ▲1.1
  • 漲幅
    +1.14%
  • 成交量
    724
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
智擎 (4162)籌碼相關-元富-城東 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw04/0104/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/209095100105110115120125May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元富-城東 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/01197.5000.0097.3011,7730.06%
2025/03/31197.7000.0096.2011,7710.06%
2025/03/2813101.1900.00100.50131,7520.74%
2025/03/272103.2500.00103.5021,7280.12%
2025/03/261104.0000.00104.5011,7230.06%
2025/03/253104.6700.00104.5031,7190.17%
2025/03/246105.2500.00105.5061,7140.35%
2025/03/2100.007107.43106.50-71,714-0.41%
2025/03/2000.001106.50106.00-11,713-0.06%
2025/03/197105.1400.00104.5071,7180.41%
2025/03/1800.0010106.55106.50-101,713-0.58%
2025/03/1700.007107.00105.00-71,714-0.41%
2025/03/143104.3300.00105.0031,7130.18%
2025/03/1312104.2100.00103.50121,7070.70%
2025/03/125107.2000.00107.0051,6950.29%
2025/03/117106.7100.00107.0071,6970.41%
2025/03/0700.0010106.70107.50-101,665-0.60%
2025/03/0614112.8900.00111.00141,6470.85%
2025/03/053114.836115.17115.50-31,645-0.18%
2025/03/041111.001114.00114.5001,6340.00%
2025/03/032113.504113.50112.50-21,620-0.12%
2025/02/279113.508111.99109.0011,5680.06%
2025/02/266114.9243118.05115.50-371,553-2.38%
2025/02/2500.002113.25113.00-21,443-0.14%
2025/02/2400.0012114.50115.00-121,431-0.84%
2025/02/2100.003113.00113.00-31,412-0.21%
2025/02/2000.001111.00110.00-11,389-0.07%
2025/02/190110.2513109.92110.00-131,396-0.93%
2025/02/182110.0012109.25110.00-101,401-0.71%
2025/02/141113.001112.00111.5001,4080.00%
2025/02/130110.754111.25111.50-41,413-0.28%
2025/02/121112.503112.83112.00-21,408-0.14%
2025/02/112109.2500.00109.0021,3920.14%
2025/02/1000.001118.50118.50-11,337-0.07%
2025/02/072118.752119.75120.5001,3510.00%
2025/02/068119.2513119.85119.00-51,329-0.38%
2025/02/052112.0012109.67113.00-101,194-0.84%
2025/02/041101.002101.60103.00-11,201-0.08%
2025/01/20193.3000.0093.6011,2790.08%
2025/01/17193.2000.0093.2011,3640.07%
2025/01/15593.76193.4093.1041,3800.29%
2025/01/09294.6000.0094.6021,3410.15%
2025/01/071104.001101.50101.5001,2750.00%
2025/01/0600.000.3100.50101.50-0.31,259-0.02%
2025/01/03198.00198.3098.3001,2400.00%
2025/01/02194.40193.8093.6001,2350.00%
2024/12/20386.9700.0086.2031,2130.25%
2024/12/1800.00588.3088.80-51,220-0.41%
2024/12/16287.55187.5086.3011,2160.08%
2024/12/13288.5000.0088.8021,2090.17%
2024/12/120.291.0000.0090.200.21,1990.02%
2024/12/11190.6000.0090.6011,1930.08%
2024/12/0400.000.194.6094.60-0.11,164-0.01%
2024/12/020.195.4000.0094.400.11,1580.01%
2024/11/290.397.20197.4097.50-0.71,136-0.06%
2024/11/28492.1500.0092.4041,1100.36%
2024/11/260.594.70194.5094.00-0.51,084-0.05%
2024/11/25193.8000.0093.8011,0790.09%
2024/11/221.293.7500.0093.801.21,0310.12%
2024/11/210.296.2000.0096.200.21,0210.01%
2024/11/1400.001105.50101.50-1971-0.10%
2024/11/121101.000.1104.00104.000.99160.10%
2024/11/110.1104.0000.00103.500.18820.01%
2024/11/0700.004105.13103.50-4852-0.47%
2024/11/062102.253107.50102.50-1826-0.12%
2024/11/051106.502106.75106.00-1782-0.13%
2024/11/043101.5031101.60100.00-28758-3.69%
2024/11/017106.0010106.65105.00-3730-0.41%
2024/10/2816102.53399.67102.00135762.25%
2024/10/25298.101098.4797.40-8513-1.56%
2024/10/2418100.0311.599.7098.306.54941.30%
2024/10/2300.00494.1093.70-4424-0.94%
2024/10/18287.05187.4086.8014500.22%
2024/10/1100.001089.2388.30-10502-1.99%
2024/10/08391.6300.0091.1035070.59%
2024/09/30389.4700.0089.5035500.54%
2024/09/26787.3400.0086.6075761.21%
2024/09/251088.6700.0088.20106091.64%
2024/09/241288.1800.0090.20126121.96%
2024/09/23587.5000.0088.0056200.81%
2024/09/20387.97187.5087.4026440.31%
2024/09/19185.0000.0086.0016360.16%
2024/09/18282.9000.0082.9026330.32%
2024/09/16582.8000.0082.7056410.78%
2024/09/11182.3000.0082.1016560.15%
2024/09/09082.5000.0082.0006660.00%
2024/09/0400.001082.1082.00-10698-1.43%
2024/08/270.186.6000.0086.500.17340.01%
2024/08/22187.20186.6086.6007400.00%
2024/08/21186.90186.5086.6007460.00%
2024/08/20185.80185.7085.8007420.00%
2024/08/06477.0700.0080.8047830.51%
2024/08/050.183.001083.0883.00-9.9764-1.30%
2024/07/30493.43492.7093.6007360.00%
2024/07/26397.27493.9397.60-1729-0.14%
2024/07/23494.13593.8494.50-1720-0.14%
2024/07/22492.55594.9092.00-1718-0.14%
2024/07/191195.40694.3394.2057080.71%
2024/07/1800.00499.1599.40-4676-0.59%
2024/07/16197.1000.0097.0016580.15%
2024/07/15198.70298.7598.40-1663-0.15%
2024/07/10197.6000.0096.6016580.15%
2024/07/0900.001101.0096.30-1668-0.15%
2024/07/0800.002100.00100.50-2655-0.31%
2024/07/02197.8000.0097.8016230.16%
2024/07/01298.65599.10101.00-3610-0.49%
2024/06/261.597.27297.7097.60-0.5576-0.09%
2024/06/21196.10194.8093.7006070.00%
2024/06/20194.40194.3094.5006350.00%
2024/06/19694.23393.8093.8036370.47%
2024/06/1800.00296.5095.40-2633-0.32%
2024/06/1300.00297.1096.90-2651-0.31%
2024/06/1200.00094.3094.8006380.00%
2024/06/11295.75295.1495.4006360.00%
2024/06/07193.30693.7794.50-5644-0.78%
2024/06/05190.70292.0092.90-1632-0.16%
2024/06/0400.00190.8090.80-1647-0.15%
2024/06/03190.6000.0090.7016930.14%
2024/05/3100.00391.0090.60-3729-0.41%
2024/05/30090.5000.0090.3007370.00%
2024/05/2800.00192.0092.30-1760-0.13%
2024/05/27291.65191.4091.7017760.13%
2024/05/23094.5000.0093.6008420.00%
2024/05/22194.8000.0094.1018470.12%
2024/05/2000.003097.8096.90-30865-3.47%
2024/05/17398.53397.9797.9008720.00%
2024/05/1500.00194.4093.90-1952-0.11%
2024/05/144296.101295.3694.30301,0432.87%
2024/05/130.192.6200.0092.600.11,0380.01%
2024/05/09493.4800.0093.3041,0720.37%
2024/05/0600.00194.1093.40-11,175-0.09%
2024/04/29193.8000.0095.3011,4300.07%
2024/04/160.191.00192.9091.00-0.91,557-0.06%
2024/04/1200.00197.3097.10-11,579-0.06%
2024/04/10199.80198.9098.8001,6420.00%
2024/04/03199.6000.0099.0011,7770.06%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-29天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章
 
 
421小時46